XM does not provide services to residents of the United States of America.

Hedge funds buy health care and sell real estate, says Goldman Sachs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>HEDGE FLOW-Hedge funds buy health care and sell real estate, says Goldman Sachs</title></head><body>

By Nell Mackenzie

LONDON, Oct 7 (Reuters) -Hedge funds bought health care stocks at the fastest pace in five months, a Goldman Sachs prime brokerage note showed, on bets these stocks that are sensitive to borrowing costs will rise as a global rate cutting cycle picks up.

Health care stocks were among the most net bought sectors on Goldman Sachs' GS.N trading desk last week, said the note sent to clients on Friday and seen by Reuters on Monday.

Consumer spending, or PCE, the Federal Reserve's measure of U.S. inflation, rose 0.2% last month after an unrevised 0.5% gain in July, the Commerce Department's Bureau of Economic Analysis said on Sept. 27.

Certain stock sectors are sensitive to this consumer spending number, noted Jim Reid, a strategist at Deutsche Bank in a note to clients on Monday.

"The market will as ever pay closest attention to the categories that feed into the core PCE deflator – namely, health care services, airfares and portfolio management," the note said.

Last week's rush to buy health care stocks was the largest net buying in the sector for the last five months, driven by hedge funds with long bets that equities would rise, rather than those exiting short positions, the Goldman Sachs prime brokerage note said.

A short bet expects an asset price to decline.

Hedge funds bought most companies considered part of the health care stock sector, including pharmaceuticals, biotech, and health care providers and services, the Goldman Sachs note said.

Hedge funds overlooked life sciences tools and services, it said.

Speculators concentrated mostly on North America and Europe, said the note.

Health care has now been bought in five of the last six weeks, it said.

By contrast, hedge funds were most short on U.S. real estate and it was the most net sold sector on the U.S. prime brokerage trading desk last week, the Goldman note added.

Four times as many hedge funds last week took short bets against the sector as those that were long, said the bank.

Last week’s short selling, the largest since August 2023, concentrated on real estate trusts, management and development and office space trusts, said the note.



Reporting by Nell Mackenzie; Editing by Sharon Singleton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.